Carey R W, McGinnis A, Jacobson B M, Carvalho A
Arch Intern Med. 1976 Jan;136(1):62-6.
Three patients had severe, symptomatic idiopathic thrombocytopenic purpura (ITP) complicating chronic lymphocytic leukemia (CLL) that was refractory to prednisone treatment but that responded to splenectomy alone or in addition to immunosuppressive-cytotoxic treatment. Evidence of high titer of an antiplatelet factor, most likely an antibody, was corroborated in one case by the 14C-platelet serotonin release assay. This experience suggests that the treatment of ITP complicating CLL is similar to that of ITP not associated with lymphoproliferative disorders.
三名患有严重症状性特发性血小板减少性紫癜(ITP)的患者并发慢性淋巴细胞白血病(CLL),对泼尼松治疗无效,但单独行脾切除术或联合免疫抑制-细胞毒性治疗有效。在1例患者中,14C-血小板5-羟色胺释放试验证实了高滴度抗血小板因子(很可能是一种抗体)的存在。该经验表明,CLL合并ITP的治疗与不伴有淋巴增殖性疾病的ITP治疗相似。